03:44 PM EST, 11/18/2025 (MT Newswires) -- Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.8%.

The iShares Biotechnology ETF (IBB) increased 0.8%.

In corporate news, AbbVie ( ABBV ) shares added 0.1% after it said the US Food and Drug Administration approved Epkinly in combination with rituximab and lenalidomide for adults with relapsed or refractory follicular lymphoma after at least one prior treatment.

Medtronic ( MDT ) raised its full-year outlook on Tuesday as the medical device maker logged stronger-than-expected quarterly results amid broad-based revenue gains. Its shares jumped 4.8%.

Pfizer ( PFE ) is looking to raise at least $5 billion via a US dollar high-grade bond sale to help fund its acquisition of Metsera, Bloomberg reported. Pfizer ( PFE ) shares rose 1.5%.

Arrowhead Pharmaceuticals ( ARWR ) shares gained 1.8% after it said Tuesday that the US Food and Drug Administration has approved Redemplo for the treatment of adults with familial chylomicronemia syndrome.